Who owns ENLIVEN THERAPEUTICS INC?
- Ticker: ELVN
- CUSIP Number: 29337e102
Tip: Access positions for across all investors
Analyze quarterly positions in Enliven Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Enliven Therapeutics stock
Who bought or sold ENLIVEN THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
OrbiMed Advisors | 8.0M | $203M | 0% | Sep 2024 |
|
Commodore Capital | 4.1M | $105M | 3% | Sep 2024 |
|
VR Adviser | 4.0M | $103M | 0% | Sep 2024 |
|
Fairmount Funds Management | 3.2M | $82M | 0% | Sep 2024 |
|
BlackRock | 2.9M | $75M | 100% | Sep 2024 |
|
BlackRock | 2.7M | $64M | 51% | Jun 2024 |
|
Vanguard Group | 1.8M | $43M | 54% | Jun 2024 |
|
5AM Venture Management | 1.8M | $45M | -33% | Sep 2024 |
|
Citadel Advisors | 1.7M | $44M | -25% | Sep 2024 |
|
RA Capital Management | 1.1M | $27M | -50% | Sep 2024 |
|
Pictet Asset Management Holding SA | 836k | $21M | 100% | Sep 2024 |
|
Woodline Partners | 806k | $21M | 12% | Sep 2024 |
|
Soleus Capital Management | 769k | $18M | 100% | Jun 2024 |
|
Geode Capital Management | 750k | $19M | 10% | Sep 2024 |
|
Henderson Group | 729k | $17M | 2% | Jun 2024 |
|
State Street Corporation | 725k | $17M | 47% | Jun 2024 |
|
Boxer Capital | 671k | $17M | 0% | Sep 2024 |
|
Logos Global Management | 595k | $14M | -62% | Jun 2024 |
|
First Turn Management | 535k | $14M | 100% | Sep 2024 |
|
Ikarian Capital | 500k | $13M | -15% | Sep 2024 |
|
Rock Springs Capital Management | 429k | $10M | 0% | Jun 2024 |
|
Blackstone Group | 373k | $9.5M | 16% | Sep 2024 |
|
Northern Trust | 304k | $7.8M | 39% | Sep 2024 |
|
Charles Schwab Investment Management | 255k | $6.5M | 10% | Sep 2024 |
|
Cutter Capital Management | 208k | $5.3M | -7% | Sep 2024 |
|
Nicholas Investments Partners | 174k | $4.4M | 100% | Sep 2024 |
|
Saturn V Capital Management | 152k | $3.6M | 100% | Jun 2024 |
|
Marshall Wace | 138k | $3.5M | -28% | Sep 2024 |
|
Nuveen Asset Management | 128k | $3.0M | 54% | Jun 2024 |
|
Baker Bros. Advisors | 115k | $2.9M | 0% | Sep 2024 |
|
Patient Square Capital | 91k | $2.3M | 100% | Sep 2024 |
|
Bank of New York Mellon | 90k | $2.3M | -21% | Sep 2024 |
|
Morgan Stanley | 68k | $1.6M | 8% | Jun 2024 |
|
Goldman Sachs Group | 66k | $1.5M | 281% | Jun 2024 |
|
Barclays | 56k | $1.4M | 296% | Sep 2024 |
|
Rhumbline Advisers | 50k | $1.3M | 0% | Sep 2024 |
|
Bank of America Corporation | 49k | $1.2M | 42% | Sep 2024 |
|
Alliancebernstein | 37k | $861k | 130% | Jun 2024 |
|
Swiss National Bank | 37k | $939k | 0% | Sep 2024 |
|
Cantor Fitzgerald, L. P. | 33k | $845k | 100% | Sep 2024 |
|
Jane Street | 31k | $787k | -42% | Sep 2024 |
|
Citigroup | 29k | $737k | 173% | Sep 2024 |
|
New York State Common Retirement Fund | 28k | $703k | 19% | Sep 2024 |
|
Quest Partners | 21k | $539k | 1226% | Sep 2024 |
|
Jpmorgan Chase & Co | 21k | $531k | 0% | Sep 2024 |
|
MetLife Investment Advisors | 21k | $523k | 0% | Sep 2024 |
|
Franklin Resources | 20k | $559k | 100% | Sep 2024 |
|
Deutsche Bank Aktiengesellschaft | 20k | $514k | 32% | Sep 2024 |
|
Mirae Asset Global Etfs Holdings | 19k | $493k | 70% | Sep 2024 |
|
California State Teachers Retirement System | 19k | $485k | -3% | Sep 2024 |
|
Toroso Investments | 18k | $411k | 100% | Jun 2024 |
|
Voloridge Investment Management | 17k | $442k | 49% | Sep 2024 |
|
Two Sigma Investments | 17k | $403k | 100% | Jun 2024 |
|
Legato Capital Management | 15k | $372k | 100% | Sep 2024 |
|
Invesco | 15k | $372k | 2% | Sep 2024 |
|
Manufacturers Life Insurance Company | 14k | $322k | 100% | Jun 2024 |
|
T. Rowe Price Associates | 12k | $298k | 4% | Sep 2024 |
|
Ing Investment Management | 12k | $298k | -2% | Sep 2024 |
|
Alpine Partners VI | 11k | $262k | 100% | Jun 2024 |
|
Wells Fargo & Company | 11k | $284k | -3% | Sep 2024 |
|
Florida State Board of Administration | 11k | $268k | 0% | Sep 2024 |
|
SG Americas Securities | 10k | $256k | 100% | Sep 2024 |
|
China Universal Asset Management | 9.1k | $232k | 64% | Sep 2024 |
|
Graham Capital Management | 9.1k | $232k | 100% | Sep 2024 |
|
Exchange Traded Concepts | 7.5k | $191k | -60% | Sep 2024 |
|
Royal Bank of Canada | 3.8k | $94k | 11% | Sep 2024 |
|
Summit Investment Advisors | 3.4k | $88k | 0% | Sep 2024 |
|
Tower Research Capital | 3.2k | $76k | 541% | Jun 2024 |
|
Acadian Asset Management | 1.8k | $46k | 100% | Sep 2024 |
|
Mirae Asset Global Investments | 1.7k | $41k | 22% | Sep 2024 |
|
Russell Investments | 1.4k | $34k | 11883% | Jun 2024 |
|
Amalgamated Bank | 1.2k | $31k | 0% | Sep 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 1.2k | $31k | 100% | Sep 2024 |
|
NISA Investment Advisors | 662.00 | $17k | 1104% | Sep 2024 |
|
Capital Advisors | 302.00 | $8.0k | 0% | Sep 2024 |
|
Daiwa Securities Group | 152.00 | $4.0k | 0% | Sep 2024 |
|
SRS Capital Advisors | 103.00 | $2.6k | 0% | Sep 2024 |
|
Versant Capital Management | 67.00 | $1.7k | 100% | Sep 2024 |
|
GAMMA Investing | 66.00 | $1.7k | 35% | Sep 2024 |
|
Quarry | 52.00 | $1.2k | 100% | Jun 2024 |
|
Bessemer | 45.00 | $999.999000 | 100% | Sep 2024 |
|
Sterling Capital Management | 40.00 | $1.0k | 100% | Sep 2024 |
|
Rothschild Investment | 35.00 | $894.001500 | 600% | Sep 2024 |
|
Capital Performance Advisors | 32.00 | $816.998400 | 100% | Sep 2024 |
|
CWM | 12.00 | $0 | 71% | Sep 2024 |
|
Farther Finance Advisors | 6.00 | $153.000000 | 0% | Sep 2024 |
|
Covestor | 6.00 | $0 | 0% | Sep 2024 |
|
National Bank Of Canada /fi/ | 1.00 | $26.000000 | 100% | Sep 2024 |
|
Who sold out of Enliven Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Exome Asset Management | Mar 2024 | 58k | $1.0M |
American Century Companies | Jun 2024 | 28k | $646k |
Susquehanna International | Jun 2024 | 8.7k | $203k |
Advisor Group Holdings | Mar 2024 | 2.0k | $35k |
Meeder Asset Management | Jun 2024 | 447.00 | $10k |
EntryPoint Capital | Jun 2024 | 241.00 | $5.6k |
Simplex Trading | Jun 2024 | 93.00 | $2.0k |